Pengaruh Rasio Keuangan Terhadap Pertumbuhan Laba Pada Perusahaan Farmasi Yang Terdaftar di Perusahaan BEI Tahun 2017-2023
DOI:
https://doi.org/10.35870/jemsi.v11i1.3598Keywords:
Financial Ratios, Profit Growth, Pharmaceutical Companies, Indonesia Stock Exchange, Return On Assets (ROA), Gross Profit Margin (GPM)Abstract
Financial statements are essential for assessing the financial health and performance of a company, serving as a key tool for management to provide relevant and accurate business information to stakeholders. The main component of financial statements is the company's profit, which plays an important role in evaluating management's performance in asset management and operations. This information is critical for internal and external parties, such as shareholders, creditors, and investors, who rely on earnings data for decision-making and strategy development. Earnings are generally recorded as the difference between revenues and expenses, with net income and earnings per share as commonly used measures. Accurate and consistent earnings reporting, supported by transparent accounting standards, is fundamental to informed decision-making. This study explores the impact of financial ratios on earnings growth in pharmaceutical companies listed on the Indonesia Stock Exchange (IDX) from 2017 to 2023. The pharmaceutical sector, with its unique characteristics and challenges, such as dependence on research and development (R&D) and government regulations, exhibits different dynamics compared to other industries. Previous research has mostly focused on the manufacturing and services sectors, with limited research on the pharmaceutical sector. This study aims to fill this gap by examining the relationship between financial ratios, such as Return on Assets (ROA), Return on Equity (ROE), and Gross Profit Margin (GPM), to earnings growth in the pharmaceutical sector.
Downloads
References
Aisyah, R., & Widhiastuti, R. N. (2021). Pengaruh rasio keuangan terhadap pertumbuhan laba pada perusahaan industri makanan dan minuman yang terdaftar di bei periode 2010-2019. Remittance: Jurnal Akuntansi Keuangan Dan Perbankan, 2(1), 1-9. https://doi.org/10.30596/jakk.v4i1.6846.
Amanda, N., & Nur Fani Arisawati, M. M. (2023). Pengaruh Long Term Debt to Equity Ratio, Working Capital to Total Asset Terhadap Pertumbuhan Laba dengan Return on Equity sebagai Variabel Moderasi (Studi Empiris pada Perusahaan Sub Sektor Otomotif & Komponen yang Terdaftar di BEI Tahun 2018-2022.
Anggraini, S. D., Setiono, H., & Isnaini, N. F. (2024). PENGARUH GROSS PROFIT MARGIN (GPM), NET PROFIT MARGIN (NPM), RETURN ON ASSETS (ROA), RETURN ON EQUITY (ROE), DAN KEBIJAKAN KEPEMIMPINAN TERHADAP PERTUMBUHAN LABA DENGAN GOOD CORPORATE GOVERNANCE SEBAGAI MODERASI (STUDI PADA PERUSAHAAN TELEKOMUNIKASI YANG TERDAFTAR DI BEI PERIODE 2020-2023) (Doctoral dissertation, Universitas Islam Majapahit).
Desyana, G., Gowira, D., & Jennifer, M. (2023). Pengaruh Leverage, Ukuran Perusahaan, Pertumbuhan Laba, Dan Profitabilitas Terhadap Kualitas Laba: Studi Pada Perusahaan Basic Materials Yang Terdaftar Di Bursa Efek Indonesia Tahun 2017-2021. Jurnal Eksplorasi Akuntansi, 5(3), 1139-1152. https://doi.org/10.24036/jea.v5i3.908.
Dianitha, K. A., Masitoh, E., & Siddi, P. (2020). Pengaruh rasio keuangan terhadap pertumbuhan laba pada perusahaan makanan dan minuman di BEI. Jurnal Akuntansi: Transparansi Dan Akuntabilitas, 8(2), 127-136.
Istiqomah, N. A., & Andayani, A. (2023). Pengaruh rasio keuangan terhadap pertumbuhan laba. Jurnal Ilmu dan Riset Akuntansi (JIRA), 12(2).
Kalsum, U. (2021). Pengaruh rasio keuangan terhadap pertumbuhan laba pada perusahaan LQ45 yang terdaftar di BEI. Jurnal Akuntansi Dan Keuangan Kontemporer (JAKK), 4(1), 25-32.
Lesmana (2022). Pengaruh Rasio Keuangan Terhadap Pertumbuhan Laba. Jurnal Neraca Peradaban, 2(2), 113–122. https://doi.org/10.55182/jnp.v2i2.177.
Mahaputra, I. N. K. A., & Adnyana, N. K. (2012). Pengaruh rasio-rasio keuangan terhadap pertumbuhan laba pada perusahaan manufaktur yang terdaftar di BEI. Jurnal Akuntansi & Bisnis, 7(2), 243-254.
Mujizat, M., & Retnaningdiah, D. (2022). Analisis Kinerja Keuangan Sebelum dan Selama Pandemi Covid-19 pada Perusahaan Farmasi Yang Terdaftar di Bursa Efek Indonesia. Journal Competency of Business, 6(02), 39-53.
Nasution, Y., & Sitorus, G. (2022). Pengaruh Current Ratio (CR), Debt To Equity Ratio (DER), Dan Total Assets Turnover (TATO) Terhadap Pertumbuhan Laba Pada Perusahaan Manufaktur Sektor Industri Dasar Dan Kimia Yang Terdaftar Di Bursa Efek Indonesia Tahun 2017-2020. Jurnal Manajemen, 6(2), 61-72.
Nurlia, N. (2018). Pengaruh Net Profit Margin (NPM), Return on Equity (ROE), Earning per Share (EPS) Dan Price Earning Ratio (PER) terhadap Return Saham pada Perusahaan Farmasi Yang Terdaftar di Bursa Efek Indonesia. Jurnal GeoEkonomi, 9(1), 60-74. https://doi.org/10.36277/geoekonomi.v9i1.19.
Permana, K. W. A., Saleh, R., Sari, L., & Sutandi, S. (2021). Analisis Return On Assets (ROA), Return On Equity (ROE), Net Profit Margin (NPM) Dan Gross Profit Margin Untuk Mengukur Kinerja Keuangan Pada PT Raje Baginda Jurai Di Palembang. JURNAL EKOBIS Kajian Ekonomi dan Bisnis, 5(1), 53-70.
Rahmani, N. A. B. (2020). Pengaruh Return On Assets (ROA), Return On Equity (ROE), Net Profit Margin (NPM), Dan Gross Profit Margin (GPM) Terhadap Harga Saham Perbankan Syariah Periode Tahun 2014-2018. HUMAN FALAH: Jurnal Ekonomi Dan Bisnis Islam, 7(1).
Ulya, S. U. S., Safrizal, S., Masril, M., & Zubir, Z. (2024). Sektor Farmasi Bursa Efek Indonesia: Determinasi Profitabilitas Perusahaan. Surplus: Jurnal Riset Mahasiswa Ekonomi, Manajemen, dan Akuntansi, 4(1), 46-56. https://doi.org/10.35449/surplus.v4i1.807.
Downloads
Published
Issue
Section
License
Authors who publish with this journal agree to the following terms:
1. Copyright Retention and Open Access License
Authors retain copyright of their work and grant the journal non-exclusive right of first publication under the Creative Commons Attribution 4.0 International License (CC BY 4.0).
This license allows unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
2. Rights Granted Under CC BY 4.0
Under this license, readers are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, including commercial use
- No additional restrictions — the licensor cannot revoke these freedoms as long as license terms are followed
3. Attribution Requirements
All uses must include:
- Proper citation of the original work
- Link to the Creative Commons license
- Indication if changes were made to the original work
- No suggestion that the licensor endorses the user or their use
4. Additional Distribution Rights
Authors may:
- Deposit the published version in institutional repositories
- Share through academic social networks
- Include in books, monographs, or other publications
- Post on personal or institutional websites
Requirement: All additional distributions must maintain the CC BY 4.0 license and proper attribution.
5. Self-Archiving and Pre-Print Sharing
Authors are encouraged to:
- Share pre-prints and post-prints online
- Deposit in subject-specific repositories (e.g., arXiv, bioRxiv)
- Engage in scholarly communication throughout the publication process
6. Open Access Commitment
This journal provides immediate open access to all content, supporting the global exchange of knowledge without financial, legal, or technical barriers.
